Altis Biosystems Welcomes Joshua Taylor as Director of Business Development
June 1, 2023
Altis Biosystems provides human derived cell based pre-clinical testing services and products for the pharmaceutical and biotechnology markets. The core technology, RepliGut, features a layer of human intestinal stem and differentiated cells – either of the large or small intestine – that can be used for compound screening, disease modeling, and microbiome research. The platform can be used to study many aspects of drug disposition including toxicity, metabolism, drug absorption, and efficacy.
In his new role, Joshua will be managing key business within the current pipeline, identifying new areas of potential growth, and educating the client base on Altis’ various portfolio of capabilities.
Previously, Joshua spent over 15 years working within the Life Sciences industry, focused largely within the realm of tissue culture, cell culture, and laboratory services. His career started after undergrad where he spent several years working in fungal, bacterial, and mammalian cell culture production. This soon led to a role with BioIVT, where he managed their Custom Products division. During this time Joshua also went back to graduate school to pursue a Master’s in Science and an MBA.
“We are excited to have Josh join the Altis team! We are looking forward to having his sales and his expertise within the pharmaceutical and biotech space help support our Key Accounts. His previous experience working specifically with cell culture, both human and animal, will help enhance our customers’ interactions with Altis Biosystems,” said Niki Heinz, Senior Director of Business Development at Altis Biosystems.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
